Group One Trading’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,000
| Closed | -$7.42K | – | 8073 |
|
|
2026
Q1 | $7.42K | Sell |
1,000
-2,100
| -68% | -$13.7K | ﹤0.01% | 6532 |
|
|
2025
Q4 | $19.5K | Buy |
3,100
+3,000
| +3,000% | +$17.5K | ﹤0.01% | 6352 |
|
|
2025
Q3 | $390 | Buy |
+100
| New | +$410 | ﹤0.01% | 8173 |
|
|
2024
Q1 | – | Sell |
-10
| Closed | -$95 | – | 7519 |
|
|
2023
Q4 | $95 | Sell |
10
-30
| -75% | -$264 | ﹤0.01% | 7201 |
|
|
2023
Q3 | $476 | Buy |
40
+10
| +33% | +$177 | ﹤0.01% | 7347 |
|
|
2023
Q2 | $735 | Buy |
30
+20
| +200% | +$521 | ﹤0.01% | 7319 |
|
|
2023
Q1 | $313 | Sell |
10
-40
| -80% | -$2.31K | ﹤0.01% | 6957 |
|
|
2022
Q4 | $3.52K | Sell |
50
-19,650
| -100% | -$1.46M | ﹤0.01% | 6480 |
|
|
2022
Q3 | $1.7M | Sell |
19,700
-7,640
| -28% | -$742K | ﹤0.01% | 2060 |
|
|
2022
Q2 | $2.26M | Buy |
27,340
+24,790
| +972% | +$2.19M | ﹤0.01% | 1944 |
|
|
2022
Q1 | $424K | Sell |
2,550
-1,870
| -42% | -$268K | ﹤0.01% | 3999 |
|
|
2021
Q4 | $739K | Buy |
4,420
+4,400
| +22,000% | +$497K | ﹤0.01% | 3667 |
|
|
2021
Q3 | $2K | Sell |
20
-110
| -85% | -$7.28K | ﹤0.01% | 7940 |
|
|
2021
Q2 | $7K | Sell |
130
-20
| -13% | -$1.14K | ﹤0.01% | 7650 |
|
|
2021
Q1 | $9K | Buy |
150
+60
| +67% | +$3.51K | ﹤0.01% | 7087 |
|
|
2020
Q4 | $5K | Hold |
90
| – | – | ﹤0.01% | 6019 |
|
|
2020
Q3 | $4K | Buy |
90
+10
| +13% | +$478 | ﹤0.01% | 5679 |
|
|
2020
Q2 | $4K | Buy |
+80
| New | +$4.04K | ﹤0.01% | 5427 |
|
Group One Trading's KZR Position: Q3 2023 in Review
Group One Trading sold out of Kezar Life Sciences (KZR) in Q3 2023, closing a stake of 1,344 shares — an estimated $23.8K sold.
Group One Trading first reported a position in KZR in Q2 2020 and held it in 10 quarters. The position peaked at $763K in Q2 2022. 82 funds tracked by Wall St. Rank hold KZR as of Q3 2023.
- Group One Trading reported no remaining Kezar Life Sciences position as of Q3 2023 after selling out during the quarter.
- Group One Trading sold 1,344 Kezar Life Sciences shares in Q3 2023, an estimated $23.8K.
- Group One Trading first reported a position in Kezar Life Sciences in Q2 2020 and held it in 10 quarters.
- Group One Trading's Kezar Life Sciences position peaked at $763K in Q2 2022.
- 82 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2023.
Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.